Y-mAbs Therapeutics
Pre-clinicalOur mission is to deliver innovative therapeutic solutions for life-threatening diseases to improve and extend people’s lives.
Founded
2015
Focus
AntibodiesBiologics
About
Our mission is to deliver innovative therapeutic solutions for life-threatening diseases to improve and extend people’s lives.
Funding History
4Total raised: $280M
PIPE$125MRA Capital ManagementDec 15, 2020
IPO$85MUndisclosedAug 10, 2018
Series B$50MNovo HoldingsMar 15, 2017
Series A$20MNovo HoldingsJun 15, 2015
Company Info
TypePrivate
Founded2015
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile